Ernest Smith - Vaccinex Senior Officer
Executive
Ernest Smith is Senior Officer of Vaccinex
| Age | 52 |
| Phone | 585 271 2700 |
| Web | https://www.vaccinex.com |
Vaccinex Management Efficiency
The company has return on total asset (ROA) of (4.9564) % which means that it has lost $4.9564 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.5909) %, meaning that it created substantial loss on money invested by shareholders. Vaccinex's management efficiency ratios could be used to measure how well Vaccinex manages its routine affairs as well as how well it operates its assets and liabilities.Vaccinex currently holds 247 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Vaccinex has a current ratio of 8.06, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Vaccinex's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jathin MD | Protara Therapeutics | 36 | |
| Patrick MBA | Protara Therapeutics | 57 | |
| Paul Little | Eledon Pharmaceuticals | 60 | |
| John Herberger | Eledon Pharmaceuticals | N/A | |
| Leesa Gentry | RenovoRx | 55 | |
| Esther Jhun | Surrozen | N/A | |
| Ryan Witt | RenovoRx | N/A | |
| Michael Varney | Erasca Inc | 67 | |
| Bryan JD | Eledon Pharmaceuticals | 46 | |
| MS CPA | Erasca Inc | 58 | |
| Chandra MS | Erasca Inc | 54 | |
| Robert Strasser | RenovoRx | N/A | |
| Mary JD | Protara Therapeutics | N/A | |
| Mary Grendell | Protara Therapeutics | N/A | |
| MPH MD | Salarius Pharmaceuticals | N/A | |
| Daniel George | Anebulo Pharmaceuticals | 55 | |
| Esq JD | Erasca Inc | 52 | |
| Thomas OBrien | GeoVax Labs | N/A | |
| Robert Shoemaker | Erasca Inc | 44 | |
| Mark Conley | SAB Biotherapeutics | N/A | |
| JD Esq | Erasca Inc | 53 | |
Management Performance
| Return On Equity | -7.59 | ||||
| Return On Asset | -4.96 |
Vaccinex Leadership Team
Elected by the shareholders, the Vaccinex's board of directors comprises two types of representatives: Vaccinex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vaccinex. The board's role is to monitor Vaccinex's management team and ensure that shareholders' interests are well served. Vaccinex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vaccinex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jill CPA, Chief Officer | ||
| Jill Sanchez, Interim Controller | ||
| MBA CFA, Chief Officer | ||
| Ernest Smith, Senior Officer | ||
| Maurice Zauderer, CEO, CoFounder | ||
| Elizabeth Evans, COO Medicine | ||
| John Leonard, Senior Development |
Vaccinex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vaccinex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.59 | ||||
| Return On Asset | -4.96 | ||||
| Current Valuation | 1.59 M | ||||
| Shares Outstanding | 2.68 M | ||||
| Shares Owned By Insiders | 11.50 % | ||||
| Shares Owned By Institutions | 51.30 % | ||||
| Number Of Shares Shorted | 62.11 K | ||||
| Price To Book | 7.34 X | ||||
| Price To Sales | 4.34 X | ||||
| Revenue | 570 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |